MX354124B - Aplicacion de alto cizallamiento en terapia medica. - Google Patents

Aplicacion de alto cizallamiento en terapia medica.

Info

Publication number
MX354124B
MX354124B MX2012012667A MX2012012667A MX354124B MX 354124 B MX354124 B MX 354124B MX 2012012667 A MX2012012667 A MX 2012012667A MX 2012012667 A MX2012012667 A MX 2012012667A MX 354124 B MX354124 B MX 354124B
Authority
MX
Mexico
Prior art keywords
high shear
therapeutic
liquid
source
shear device
Prior art date
Application number
MX2012012667A
Other languages
English (en)
Other versions
MX2012012667A (es
Inventor
Abbas Hassan
Rayford G Anthony
Aziz Hassan
Original Assignee
Hrd Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hrd Corp filed Critical Hrd Corp
Publication of MX2012012667A publication Critical patent/MX2012012667A/es
Publication of MX354124B publication Critical patent/MX354124B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
    • B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/272—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed axially between the surfaces of the rotor and the stator, e.g. the stator rotor system formed by conical or cylindrical surfaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

En esta descripción, un método se describe en donde el método comprende la mezcla de un gas terapéutico o líquido terapéutico una combinación de los mismos y un portador líquido en un dispositivo de cizalla alto para producir una dispersión, y la administración de la dispersión producida intravenosamente a un paciente, en donde en la dispersión producida contiene nanoburbujas del gas terapéutico o gotas del líquido terapéutico con un diámetro promedio de menos de aproximadamente 1.5 pm. En esta descripción, un sistema también se describe en donde el sistema comprende una fuente de gas terapéutico o fuente de líquido terapéutico o una combinación de los mismos; una fuente portadora líquida; un dispositivo de cizalla alto (HSD) que tiene una entrada, una salida, al menos un rotor, y al menos un estator separado por un espacio de cizalla y una bomba configurada para controlar la velocidad de fluido y el tiempo de residencia de un fluido que pasa a través del dispositivo de cizalla alto.
MX2012012667A 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en terapia medica. MX354124B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33010410P 2010-04-30 2010-04-30
US35544810P 2010-06-16 2010-06-16
PCT/US2011/031725 WO2011139478A2 (en) 2010-04-30 2011-04-08 High shear application in medical therapy

Publications (2)

Publication Number Publication Date
MX2012012667A MX2012012667A (es) 2012-12-17
MX354124B true MX354124B (es) 2018-02-14

Family

ID=44858409

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012012667A MX354124B (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en terapia medica.
MX2012012668A MX2012012668A (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en administracion de farmaco.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2012012668A MX2012012668A (es) 2010-04-30 2011-04-08 Aplicacion de alto cizallamiento en administracion de farmaco.

Country Status (13)

Country Link
US (4) US8888735B2 (es)
EP (2) EP2563338A4 (es)
JP (3) JP2013527845A (es)
KR (3) KR101818659B1 (es)
CN (3) CN102883758B (es)
AU (2) AU2011248866B2 (es)
BR (2) BR112012027634A2 (es)
CA (2) CA2798049C (es)
DK (1) DK2563426T3 (es)
EA (2) EA025125B1 (es)
ES (1) ES2663572T3 (es)
MX (2) MX354124B (es)
WO (2) WO2011139479A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012126649A (ja) * 2010-12-13 2012-07-05 Satoshi Anai 膀胱癌増殖抑制用組成物
US9421477B2 (en) * 2013-08-12 2016-08-23 Green Extraction Technologies Biomass fractionation and extraction apparatus
US10201789B2 (en) * 2013-12-27 2019-02-12 Sintokogio, Ltd. Dispersing device, a dispersing system, and a process for dispersing
JP2016063804A (ja) * 2013-12-27 2016-04-28 亀井 一郎 ミトコンドリア活性化組成物
JP6574785B2 (ja) * 2014-11-24 2019-09-11 有限会社中島工業 患部浸透亢進性薬剤組成物の製造方法
CN104803467A (zh) * 2015-04-24 2015-07-29 刘芮萌 一种微纳米气泡发生装置
JP6977979B2 (ja) * 2015-06-09 2021-12-08 国立大学法人大阪大学 神経損傷治療又は予防用医薬
US10011804B2 (en) * 2015-08-21 2018-07-03 Ecoxtraction, Llc Method of extracting CBD, THC, and other compounds from cannabis using controlled cavitation
KR102442879B1 (ko) * 2016-03-11 2022-09-14 몰레에르, 인크 액체 캐리어에 나노-버블을 함유하는 조성물
WO2017195852A1 (ja) * 2016-05-13 2017-11-16 シグマテクノロジー有限会社 生体投与可能な水溶液及びその製造方法
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
CN105997513A (zh) * 2016-06-15 2016-10-12 魏会芳 一种粉碎煎药保温装置
GB201612925D0 (en) 2016-07-26 2016-09-07 Provensis Ltd Method and device for generating injectable foam
US20200397968A1 (en) * 2018-03-05 2020-12-24 Demetris Yannopoulos Devices And Methods To Infuse Gases Into And Out Of Blood
WO2019244097A1 (en) * 2018-06-22 2019-12-26 Johnson & Johnson Consumer Inc. Process for formation of emulsion containing liquid crystal structure
US20220062837A1 (en) * 2018-12-21 2022-03-03 Nanorial Technologies Ltd. Apparatus, methods, and systems for mixing, dispersing substances
KR102474965B1 (ko) 2019-07-01 2022-12-07 오크우드 레버러토리즈, 엘엘씨 마이크로스피어 및 에멀션 제조하기 위한 시스템 및 방법
US12005130B2 (en) * 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
US12097512B2 (en) 2020-06-16 2024-09-24 FineFlot Inc. System and method for saturation of a multicomponent medium with active microbubbles
CN117282303B (zh) * 2023-11-24 2024-02-06 吉林农业科技学院 一种食品乳化罐

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887167A (en) 1971-02-09 1975-06-03 Du Pont Apparatus for manufacture of organic isocyanates
DE3381777D1 (de) 1982-12-09 1990-09-06 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
GB8431012D0 (en) * 1984-12-07 1985-01-16 British Petroleum Co Plc Preparation of emulsions
US5279463A (en) 1992-08-26 1994-01-18 Holl Richard A Methods and apparatus for treating materials in liquids
US20070117863A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE4428018A1 (de) 1994-08-08 1996-02-15 Bayer Ag Verfahren zur Herstellung von aromatischen Aminen
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
US6368366B1 (en) 1999-07-07 2002-04-09 The Lubrizol Corporation Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition
US6383237B1 (en) 1999-07-07 2002-05-07 Deborah A. Langer Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel compositions
US6368367B1 (en) 1999-07-07 2002-04-09 The Lubrizol Corporation Process and apparatus for making aqueous hydrocarbon fuel compositions, and aqueous hydrocarbon fuel composition
US6471392B1 (en) 2001-03-07 2002-10-29 Holl Technologies Company Methods and apparatus for materials processing
US6742774B2 (en) 1999-07-02 2004-06-01 Holl Technologies Company Process for high shear gas-liquid reactions
US7538237B2 (en) 1999-07-02 2009-05-26 Kreido Laboratories Process for high shear gas-liquid reactions
US6530964B2 (en) 1999-07-07 2003-03-11 The Lubrizol Corporation Continuous process for making an aqueous hydrocarbon fuel
KR20020043455A (ko) * 2000-01-31 2002-06-10 콜로보라티브 테크놀러지스 인코포레이티드 주문형 개인화 화장품 및 약제 제제 생산 방법 및 시스템
GB0119480D0 (en) * 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
JP2003160477A (ja) * 2001-09-14 2003-06-03 Nof Corp 高級脂肪族アルコールの水性組成物、製造方法および投与方法
CN1571691A (zh) * 2001-10-17 2005-01-26 纳幕尔杜邦公司 产生微粒用的转子－定子设备和方法
US7098360B2 (en) 2002-07-16 2006-08-29 Kreido Laboratories Processes employing multiple successive chemical reaction process steps and apparatus therefore
CN100402412C (zh) 2002-09-11 2008-07-16 克雷多实验室 材料的高剪切混合和反应方法及装置
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
WO2004064769A2 (en) 2003-01-21 2004-08-05 Hector Herrera Methods for making and using topical delivery agents
EP1590006B1 (en) * 2003-02-04 2010-09-08 Bracco Suisse SA Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
EP1796650B1 (en) 2004-09-14 2009-01-07 NanoDel Technologies GmbH Delivery vehicle containing nanoparticles
GB0425266D0 (en) * 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
AU2005316051A1 (en) * 2004-12-13 2006-06-22 Accelergy Corporation An apparatus for processing materials
JP2008533055A (ja) 2005-03-18 2008-08-21 ナノマテリアルズ テクノロジー ピーティーイー リミテッド 吸入剤
CA2604770C (en) 2005-04-13 2013-09-24 Abbott Gmbh & Co. Kg Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof
US8732234B2 (en) 2005-06-07 2014-05-20 Yahoo! Inc. Providing relevant non-requested content to a mobile device
WO2007048019A2 (en) * 2005-10-20 2007-04-26 The Penn State Research Foundation Delivery system for diagnostic and therapeutic agents
AU2006321975A1 (en) * 2005-12-06 2007-06-14 Wyeth Interleukin-11 compositions and methods of use
US8211061B2 (en) 2006-10-23 2012-07-03 Sun Medical-Scientific (Shanghai) Co., Ltd Intelligent remote-controlled portable intravenous injection and transfusion system
CA2671447A1 (en) * 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
EP2117603A2 (en) * 2006-12-19 2009-11-18 Bracco International B.V. Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds
US7943712B2 (en) 2006-12-28 2011-05-17 The Goodyear Tire & Rubber Company Catalyst system for synthesizing amine functionalized rubbery polymers having a high trans microstructure
US7910758B2 (en) * 2007-01-02 2011-03-22 H R D Corporation Catalytic hydrogenation process for the production of low trans fat-containing triglycerides
CN100569294C (zh) * 2007-04-13 2009-12-16 西安力邦制药有限公司 一种静脉注射用高稳定长循环脂肪乳载药制剂
US8461377B2 (en) 2007-06-27 2013-06-11 H R D Corporation High shear process for aspirin production
US8026403B2 (en) 2007-06-27 2011-09-27 H R D Corporation System and process for production of liquid product from light gas
WO2009003111A2 (en) * 2007-06-27 2008-12-31 H R D Corporation High shear process for dextrose production
US8282266B2 (en) * 2007-06-27 2012-10-09 H R D Corporation System and process for inhibitor injection
US8034970B2 (en) * 2007-06-27 2011-10-11 H R D Corporation Method of making phthalic acid diesters
US9205388B2 (en) 2007-06-27 2015-12-08 H R D Corporation High shear system and method for the production of acids
US8034972B2 (en) * 2007-06-27 2011-10-11 H R D Corporation System and process for production of toluene diisocyanate
US8026402B2 (en) * 2007-06-27 2011-09-27 H R D Corporation High shear process for cyclohexane production
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物
US9574155B2 (en) 2008-07-02 2017-02-21 Nanotech Lubricants, LLC Lubricant with nanodiamonds and method of making the same
EP2334353A4 (en) * 2008-10-01 2013-03-27 H R D Corp USE OF SCHOOL TREATMENT FOR DISEASE TREATMENT
EP2389160B1 (en) 2009-01-23 2017-09-13 Evonik Corporation Continuous double emulsion process for making microparticles
WO2011106565A1 (en) * 2010-02-24 2011-09-01 Travers William A Methods and devices for controlling particle size and particle size distribution
US20120070475A1 (en) * 2010-03-11 2012-03-22 Pepsico, Inc Zero Calorie Polyphenol Aqueous Dispersions
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders

Also Published As

Publication number Publication date
EA025125B1 (ru) 2016-11-30
EP2563426A2 (en) 2013-03-06
DK2563426T3 (en) 2018-04-16
CA2797913A1 (en) 2011-11-10
AU2011248866A1 (en) 2012-10-18
JP2013524937A (ja) 2013-06-20
KR20130080786A (ko) 2013-07-15
CN107088374A (zh) 2017-08-25
US20110268659A1 (en) 2011-11-03
AU2011248867B2 (en) 2014-12-04
CN102883758A (zh) 2013-01-16
US20140066852A1 (en) 2014-03-06
JP2013527845A (ja) 2013-07-04
EA201291018A1 (ru) 2013-04-30
CA2798049A1 (en) 2011-11-10
EP2563338A2 (en) 2013-03-06
CN102883758B (zh) 2016-10-12
AU2011248866B2 (en) 2014-04-03
WO2011139479A3 (en) 2012-05-03
WO2011139478A2 (en) 2011-11-10
BR112012027634A2 (pt) 2016-08-09
EA201291019A1 (ru) 2013-04-30
US8609115B2 (en) 2013-12-17
WO2011139478A3 (en) 2012-04-05
EP2563426A4 (en) 2014-06-18
JP2016019746A (ja) 2016-02-04
JP5759533B2 (ja) 2015-08-05
US8888735B2 (en) 2014-11-18
EP2563426B1 (en) 2018-01-03
EA029314B1 (ru) 2018-03-30
AU2011248867A1 (en) 2012-10-18
CN102869348A (zh) 2013-01-09
US9381138B2 (en) 2016-07-05
US20140081198A1 (en) 2014-03-20
BR112012027651A2 (pt) 2016-08-16
MX2012012668A (es) 2012-12-17
KR101818659B1 (ko) 2018-01-15
WO2011139479A2 (en) 2011-11-10
CA2798049C (en) 2016-09-20
EP2563338A4 (en) 2014-06-18
ES2663572T3 (es) 2018-04-13
KR20180064560A (ko) 2018-06-14
CA2797913C (en) 2015-06-16
KR20130080785A (ko) 2013-07-15
MX2012012667A (es) 2012-12-17
US20110270156A1 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
MX354124B (es) Aplicacion de alto cizallamiento en terapia medica.
IN2014DN08428A (es)
EP4233861A3 (en) Compositions for treatment of essential tremor
WO2012042323A3 (en) Apparatus for extracorporeal treatment of blood
WO2012025814A3 (en) Infusion control device
EP1937343A4 (en) SYSTEM AND METHOD FOR THE ADMINISTRATION OF A PHARMACEUTICAL GAS TO A PATIENT
WO2012114337A3 (en) A device for administering therapeutic substances using a high velocity liquid-gas stream
EP4295871A3 (en) Fluid management system and methods
CA2782673C (en) Advanced step therapy delivery for an ambulatory infusion pump and system
MX2010002935A (es) Bombas de infusion de alta precision.
BR112012027442B1 (pt) sistema de distribuição de solução iv para distribuição intravenosa de uma solução perigosa e método para fabricação de um dispositivo de filtro de droga perigosa para uso em combinação com um sistema de distribuição intravenosa
WO2012071307A3 (en) Medical fluid injector system
MX2011009992A (es) Dispositivo para suministrar un medicamento liquido.
WO2012138177A3 (ko) 필터 니들.
MX2022008236A (es) Metodos para administrar altas concentraciones de oxido nitrico.
MX2014002098A (es) Sistemas y metodos para la desalinizacion del agua.
BR112012021425A2 (pt) sistema de segurança para administração de droga.
BR112015012307A2 (pt) pressão positiva contínua nas vias aéreas de bolhas
WO2012175435A9 (en) Disposables for blood treatment, and methods of operating the same
WO2011089394A3 (en) Method and apparatus for providing hydration fluid
WO2012170732A3 (en) Medicament delivery systems
WO2015034967A3 (en) Hyperoxic therapy systems, methods and apparatus
MX2012011343A (es) Boquilla de cizallamiento de alta presión para el acondicionamiento en línea del lodo de perforación.
MX2016002968A (es) Dispositivos y metodos de suministros nasal de solucion salina y dioxido de carbono.
WO2013093441A3 (en) Mixing pump

Legal Events

Date Code Title Description
FG Grant or registration